Eventide Asset Management’s HYPERION THERAPEUTICS INC COM STK (DE) HPTX Stock Holding History

Eventide Asset Management’s Portfolio HPTX Stock Details HPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-76,300	Closed	-$1.83M	–	121
2014 Q4	$1.83M	Hold	76,300	–	–	0.2%	80
2014 Q3	$1.92M	Hold	76,300	–	–	0.27%	72
2014 Q2	$1.99M	Buy	76,300 +4,600	+6%	+$118K	0.27%	76
2014 Q1	$1.85M	Buy	71,700 +40,500	+130%	+$1.1M	0.29%	72
2013 Q4	$631K	Buy	+31,200	New	+$734K	0.19%	74

Other funds holding HPTX

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

WIC

Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

TAL

TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Eventide Asset Management's HPTX Position: Q1 2015 in Review

Eventide Asset Management sold out of HYPERION THERAPEUTICS INC COM STK (DE) (HPTX) in Q1 2015, closing a stake of 76,300 shares — an estimated $1.83M sold.

Eventide Asset Management first reported a position in HPTX in Q4 2013 and held it in 5 quarters. The position peaked at $1.99M in Q2 2014. 134 funds tracked by Wall St. Rank hold HPTX as of Q1 2015.

Eventide Asset Management reported no remaining HYPERION THERAPEUTICS INC COM STK (DE) position as of Q1 2015 after selling out during the quarter.
Eventide Asset Management sold 76,300 HYPERION THERAPEUTICS INC COM STK (DE) shares in Q1 2015, an estimated $1.83M.
Eventide Asset Management first reported a position in HYPERION THERAPEUTICS INC COM STK (DE) in Q4 2013 and held it in 5 quarters.
Eventide Asset Management's HYPERION THERAPEUTICS INC COM STK (DE) position peaked at $1.99M in Q2 2014.
134 funds tracked by Wall St. Rank held HYPERION THERAPEUTICS INC COM STK (DE) as of Q1 2015.

Based on Eventide Asset Management's 13F filing for Q1 2015, filed 14 May 2015.